U.S. Home Infusion Therapy Market Size

U.S. Home Infusion Therapy Market Size

U.S. Home Infusion Therapy Market size surpassed USD 11 billion in 2022 and is poised to depict over 10% CAGR through 2023-2032. This is a result of the increasing influx of chronic disease patients and high healthcare costs.

Chronic diseases continue to impact individual lifestyles and accelerate the use of medications and other diagnostic procedures. Over the years, the population of patients diagnosed with chronic conditions such as asthma, cancer, and chronic obstructive pulmonary disease, among others, has surged. Based on data from the Asthma and Allergy Foundation of America, in 2021, close to 20.4 million adults were diagnosed with asthma across the U.S. To reduce healthcare costs, asthma patients are relying on at-home infusion therapies to prevent airway inflammation.
 

Safety concerns and risks of complications associated with home infusion care may, however, assert a negative impact on industry development to a certain extent. For example, the U.S. FDA reported several issues, such as software defects, damaged mechanical parts, inadequate user interface design, and battery failures, associated with infusion pump sets. Despite these challenges, the steadily increasing number of patients with chronic ailments such as Crohn’s disease and ulcerative colitis will create lucrative growth opportunities for home infusion therapy service providers in the U.S.